Cambridge Investment Research Advisors, Inc. 10x Genomics, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,938 shares of TXG stock, worth $149,194. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,938
Previous 26,566
58.83%
Holding current value
$149,194
Previous $232,000
45.26%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TXG
# of Institutions
338Shares Held
115MCall Options Held
442KPut Options Held
149K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13.9MShares$189 Million1.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$170 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$87.2 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.01MShares$82 Million0.74% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.38MShares$73.4 Million0.04% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.3B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...